{"symbol":"DB","provider":"yahoo-finance","fetchedAt":"2025-12-23T08:21:44.256Z","asOfDate":"2025-12-23","articles":[{"id":"a02c0da3-ada3-3825-83c8-f717405e6570","title":"FRN Variable Rate Fix","url":"https://finance.yahoo.com/news/frn-variable-rate-fix-070000617.html","publisher":"Business Wire","publishedAt":"2025-12-23T07:00:00.000Z","relatedTickers":["AN3PG.AX","YT28"],"mainIdea":"FRN Variable Rate Fix","summary":"Business Wire: FRN Variable Rate Fix. LONDON, December 23, 2025-- ISIN Code. XS3037807693 Related tickers mentioned: AN3PG.AX, YT28."},{"id":"05f39f49-7dde-3e49-8f28-5dd5f50c7f68","title":"Top Analyst Reports for Eli Lilly, Shell & ICICI Bank","url":"https://finance.yahoo.com/news/top-analyst-reports-eli-lilly-221400231.html","publisher":"Zacks","publishedAt":"2025-12-22T22:14:00.000Z","relatedTickers":["FEIM","GM","IBN","LLY","MKL","RYDAF","SHEL","VASO"],"mainIdea":"Top Analyst Reports for Eli Lilly, Shell & ICICI Bank","summary":"Zacks: Top Analyst Reports for Eli Lilly, Shell & ICICI Bank. LLY's strong GLP-1 demand, international launches and new drug contributions highlight why it leads today's top analyst reports lineup. Related tickers mentioned: FEIM, GM, IBN, LLY, MKL, RYDAF, SHEL, VASO."},{"id":"779662b2-0ba1-3155-b53d-cb38576b609f","title":"DB vs. NABZY: Which Stock Should Value Investors Buy Now?","url":"https://finance.yahoo.com/news/db-vs-nabzy-stock-value-164003806.html","publisher":"Zacks","publishedAt":"2025-12-22T16:40:03.000Z","relatedTickers":["NAB.AX","NABZY","NAUBF"],"mainIdea":"DB vs. NABZY: Which Stock Should Value Investors Buy Now?","summary":"Zacks: DB vs. NABZY: Which Stock Should Value Investors Buy Now?. DB vs. NABZY: Which Stock Is the Better Value Option? Related tickers mentioned: NAB.AX, NABZY, NAUBF."}]}
